Skip to main content
GLP-1s

How Covering GLP-1 Receptor Agonists Can Enhance Workforce Health


Jan 9, 2025 12:14:27 PM

As the use of glucagon-like peptide-1 (GLP-1) receptor agonist drugs has increased, the demand for health plans to cover them has also increased, and it’s easy to see why. GLP-1 weight loss drugs can ...

Read More
Dec 31, 2024 7:45:00 AM • 4 min read
Achieving NSA and TiC Compliance: Three Ways to Support TPAs
By Vālenz Health®
Dec 30, 2024 10:00:00 AM • 3 min read
Navigating Rising Health Benefit Costs—A Road Map for Self-Insured Employers
By Vālenz Health®
Dec 3, 2024 10:30:00 AM • 3 min read
How Alternative Health Plans Can Solve Healthcare Cost and Quality Issues While Simplifying Copays
By Healthcare Bluebook
Nov 21, 2024 12:30:00 PM • 1 min read
Staff Spotlight: Jennifer Graber, CEBS
By Vālenz Health®
Nov 15, 2024 5:00:00 PM • 2 min read
Health Literacy: Key to Protecting the Patient and the Employer in Self-Insurance
By Vālenz Health®
Nov 8, 2024 7:00:00 AM • 3 min read
A female patient using a GLP-1 weight loss drug.
Investing in Health: Employer Coverage of GLP-1 Weight Loss Drugs
By Healthcare Bluebook
Oct 29, 2024 11:20:00 AM • 2 min read
Five-Year Anniversary of Vālenz® Health
By Vālenz Health®
Oct 25, 2024 7:00:00 AM • 4 min read
A group of employers review ways to integrate GLP-1s into their health benefits together.
Employer's Guide to Integrating GLP-1s into Health Benefits Packages
By Healthcare Bluebook